Fig. 2.

Fetal ovarian steroidogenic enzyme genes (mRNA) that are altered by prenatal T (T) and T plus AR antagonist (TF) treatment as determined by quantitative RT-PCR of mRNA from fetal d 65 (white bars) and fetal d 90 (black bars) whole ovarian tissue. Treatment effects on mRNA expression were determined by two-way ANOVA followed by Bonferroni post hoc tests. Differing superscripts indicate significant differences (P < 0.05). Note for 5α-reductase, the T and TF females showed a tendency to be higher compared with controls (P = 0.0795).